Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2020 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| APO-BRIVARACETAM | Apotex Inc | Marketed | Sep 10, 2024 | Marketed |
| TIMEWISE REPAIR VOLU-FIRM DAY CREAM SUNSCREEN BROAD SPECTRUM SPF 30 | mary kay cosmetics ltd | Marketed | Sep 10, 2024 | Marketed |
| BIVALIRUDIN FOR INJECTION | formative pharma inc. | Marketed | Sep 10, 2024 | Marketed |
| APO-BRIVARACETAM | Apotex Inc | Marketed | Sep 10, 2024 | Marketed |
| MAR-ESZOPICLONE | marcan pharmaceuticals inc | Marketed | Sep 3, 2024 | Marketed |
| EYLEA HD | Bayer Inc | Marketed | Sep 3, 2024 | Marketed |
| MAR-ESZOPICLONE | marcan pharmaceuticals inc | Marketed | Sep 3, 2024 | Marketed |
| TEVA-MIRTAZAPINE | teva canada limited | Marketed | Sep 3, 2024 | Marketed |
| TEVA-MIRTAZAPINE | teva canada limited | Marketed | Sep 3, 2024 | Marketed |
| MAR-ESZOPICLONE | marcan pharmaceuticals inc | Marketed | Sep 3, 2024 | Marketed |
| WIDE RANGE II DISINFECTANT CLEANER | DIVERSEY INC | Marketed | Sep 1, 2024 | Marketed |
| CAPVAXIVE | Merck Canada Inc | Marketed | Aug 29, 2024 | Marketed |
| STEQEYMA | Celltrion Inc | Marketed | Aug 29, 2024 | Marketed |
| STEQEYMA | Celltrion Inc | Marketed | Aug 29, 2024 | Marketed |
| TADALAFIL | sivem pharmaceuticals ulc | Marketed | Aug 29, 2024 | Marketed |
| TADALAFIL | sivem pharmaceuticals ulc | Marketed | Aug 29, 2024 | Marketed |
| STEQEYMA IV | Celltrion Inc | Marketed | Aug 29, 2024 | Marketed |
| TADALAFIL | sivem pharmaceuticals ulc | Marketed | Aug 29, 2024 | Marketed |
| TADALAFIL | sivem pharmaceuticals ulc | Marketed | Aug 29, 2024 | Marketed |
| JAMP TOPIRAMATE TABLETS | Jamp Pharma Corporation | Marketed | Aug 28, 2024 | Marketed |
